For Authors
About JAMA
Why publish in JAMA?
Instructions for Authors
Submit and Track Your Manuscript
JAMA-EXPRESS
Author Services
Theme Issues
JAMA Editorial Policies
Clinical Trial Registration
Depositing Research Manuscripts With An Approved Public Repository
Request to reproduce content
Contact Us
For Reviewers
Reviewer Instructions
Thank you to JAMA reviewers for 2007
For useful instructions about how to review, see Reviewing Manuscripts for Archives of Pediatrics & Adolescent Medicine by Drs Cummings and Rivara.
CME Credits for Reviewers: Reviewers who have completed their review in 21 days or less with a rating of good or better are eligible for 3 AMA PRA Category 1 Credits™ per review.
JAMA-EXPRESS
Reports of studies may be considered for JAMA-EXPRESS (Expedited Peer Review and Editorial System for Science); EXPRESS manuscripts considered undergo full peer review and, if suitable for publication after revision, may be published in print 6 weeks and online 4 weeks after submission or even faster in some cases. Studies should have immediate clinical and/or public health importance to be considered for JAMA-EXPRESS; most studies published under JAMA-EXPRESS have been large multicenter randomized controlled trials. To inquire whether your manuscript could receive EXPRESS consideration, send your manuscript with your inquiry to jamaexpress{at}jama-archives.org.
Author Services
All authors of articles published in JAMA receive access to their article's Author's Article Resource Center page. This page includes free access to the article, citing articles and related features, and monthly Web traffic to the article. The corresponding author also receives 25 free e-prints of the article (if the author's e-mail address is published with the article) and receives e-mail alerts when the article is cited by HighWire-hosted journals. Reprints are also available.
Clinical Trial Registration
As a member of the International Committee of Medical Journal Editors (ICMJE), JAMA requires, as a condition of consideration for publication, registration of all trials in a public trials registry that is acceptable to the ICMJE and that requires the minimum registration data set as described by the ICMJE (http://www.icmje.org/faq.pdf). For this purpose, a clinical trial is any study that prospectively assigns human subjects to intervention or comparison groups to evaluate the cause-and-effect relationship between a medical intervention and a health outcome. All clinical trials, regardless of when they were completed, and secondary analyses of original clinical trials must be registered before submission of a manuscript based on the trial. For clinical trials starting patient enrollment after July 2005, trials must be registered before onset of enrollment. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (eg, phase 1 trials), are exempt. Trial registry name, registration identification number, and the URL for the registry should be included at the end of the abstract and also in the space provided on the online manuscript submission form.
Trials should be registered in one of the following trial registries:
For more information about trial registration, read the editorial by Dr DeAngelis and colleagues.
If you have any questions, please contact us.
Depositing Research Manuscripts With An Approved Public Repository
All JAMA articles reporting original research are made freely available 6 months after publication, from 1998 forward, subject to certain conditions. JAMA's Editors and Publishers believe that the public is best served by accessing the freely available research articles on the journal site, to ensure access to the final published version, any corrections, and related Web features. However, some funding organizations require that authors of manuscripts reporting research deposit those manuscripts with an approved public repository, such as PubMed Central. Authors have JAMA's permission on the following conditions:
- Permission is granted only for manuscripts reporting research funded by not-for-profit organizations to be deposited in not-for-profit, publicly available repositories.
- Permission is granted to post only the manuscript reporting research that was submitted and accepted for publication but not the final, edited, formatted, and published article.
- Authors must ensure that the posted manuscript links back to the published article on the JAMA Web site to provide readers with access to the final reviewed and edited version plus any corrections and letters, as well as the article-related features only available on JAMA's Web site.
- Authors who submit their manuscripts to an approved public repository, such as PubMed Central, must indicate that the manuscript may not be made available to the public sooner than 6 months after publication in JAMA.
If authors adhere to these requirements, they may submit the final accepted version of the manuscript to the repository, if and only if the repository ensures that the deposited manuscript will not be made available to the public during the 6 month embargo following publication in JAMA.
The published article is protected by copyright at the time of publication and thereafter (see http://pubs.ama-assn.org/misc/conditions.dtl). This research access policy does not include permission to use the JAMA logo and trademarks. The JAMA article of record is the final published version; JAMA assumes no responsibility for earlier versions because substantive changes and corrections may occur during the post-acceptance editing process. Authors may contact JAMA with any questions at jama-comments{at}jama-archives.org.
